JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004359200 on September 8, 2000

J. Biol. Chem., Vol. 275, Issue 47, 37296-37302, November 24, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/47/37296    most recent
M004359200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yap, D. B. S.
Right arrow Articles by Lu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yap, D. B. S.
Right arrow Articles by Lu, X.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mdm2 Inhibits the Apoptotic Function of p53 Mainly by Targeting It for Degradation*

Damian B. S. Yap, Jung-Kuang Hsieh, and Xin LuDagger

From the Ludwig Institute for Cancer Research, Imperial College of Science, Technology and Medicine at St. Mary's Campus, Norfolk Place, London, W2 1PG United Kingdom

The ability of Mdm2 to inhibit the activities of a C-terminal truncated p53 mutant, p53-Delta 30, which can bind Mdm2 but is resistant to Mdm2-mediated protein degradation was investigated. The inhibitory function of an Mdm2 mutant, Mdm2-Delta (222-437), which can bind p53 but is defective in targeting p53 for degradation was also studied. We have demonstrated that targeting p53 for degradation is the most effective way for Mdm2 to inhibit the apoptotic function of p53. However, we have also shown that Mdm2 can inhibit the transactivation function of p53 without targeting it for degradation, although Mdm2 releases the transrepression ability of p53 mainly by targeting it for degradation. The ability of Mdm2 to inhibit the apoptotic function of p53 was linked to its ability to inhibit the transrepression but not the transactivation function of p53. Furthermore, we have demonstrated that the transrepression function of p53 was specific to p53-induced apoptosis and was not simply a result of cell death.


* This work was supported by Ludwig Inst. for Cancer Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 44-207-563-7710; Fax: 44-207-724-8586; E-mail: x.lu@ic.ac.uk.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
N Nakashima, K Kuwano, T Maeyama, N Hagimoto, M Yoshimi, N Hamada, M Yamada, and Y Nakanishi
The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia
J. Clin. Pathol., June 1, 2005; 58(6): 583 - 589.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Gronroos, A. A. Terentiev, T. Punga, and J. Ericsson
YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress
PNAS, August 17, 2004; 101(33): 12165 - 12170.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. B. S. Yap, J.-K. Hsieh, S. Zhong, V. Heath, B. Gusterson, T. Crook, and X. Lu
Ser392 Phosphorylation Regulates the Oncogenic Function of Mutant p53
Cancer Res., July 15, 2004; 64(14): 4749 - 4754.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Mancini, F. Gentiletti, M. D'Angelo, S. Giglio, S. Nanni, C. D'Angelo, A. Farsetti, G. Citro, A. Sacchi, A. Pontecorvi, et al.
MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis
J. Biol. Chem., February 27, 2004; 279(9): 8169 - 8180.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Yousfi, F. Lasmoles, V. El Ghouzzi, and P. J. Marie
Twist haploinsufficiency in Saethre-Chotzen syndrome induces calvarial osteoblast apoptosis due to increased TNF{alpha} expression and caspase-2 activation
Hum. Mol. Genet., February 1, 2002; 11(4): 359 - 369.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Heessen, A. Leonchiks, N. Issaeva, A. Sharipo, G. Selivanova, M. G. Masucci, and N. P. Dantuma
Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis
PNAS, January 17, 2002; (2002) 22306499.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Heessen, A. Leonchiks, N. Issaeva, A. Sharipo, G. Selivanova, M. G. Masucci, and N. P. Dantuma
Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis
PNAS, February 5, 2002; 99(3): 1532 - 1537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.